Developer docs
API playgroundTry for free, no card

Search company profiles

Biohellenika

Full company profile

uuid0027enb

Namestring
Biohellenika
Legal namestring
BIOHELLENIKA ΑΝΩΝΥΜΟΣ ΕΤΑΙΡΙΑ – ΕΤΑΙΡΙΑ ΕΝΤΑΣΗΣ ΓΝΩΣΗΣ – ΜΕΤΑΦΟΡΑΣ ΤΕΧΝΟΓΝΩΣΙΑΣ – ΤΕΧΝΟΛΟΓΙΑΣ – ΒΙΟΤΕΧΝΟΛΟΓΙΑΣ – ΠΑΡΟΧΗΣ ΥΠΗΡΕΣΙΩΝ ΚΑΙ ΣΥΜΒΟΥΛΩΝ
Websiteurl
biohellenika.gr
Company typeenum
Private
Founded yearint
2006
Descriptiontext

Biohellenika is a Greek biotechnology company founded in 2006 in Thessaloniki, specializing in the collection, processing, and long-term cryogenic storage of hematopoietic and mesenchymal stem cells from umbilical cord blood, umbilical cord tissue, and placenta at childbirth. The company also collects Very Small Embryonic-Like Stem Cells (VSELs) from cord blood and operates an in-house molecular laboratory offering non-invasive prenatal testing (NIPT), DNA paternity testing, pharmacogenomics, cardiovascular and thrombosis testing, HPV detection, celiac/lactose intolerance testing, microbiome analysis, and infertility diagnostics. Additional service lines include platelet-rich plasma (PRP) applications in orthopedics, gynecology, and individualized facial skincare, plus a Medical Advisory Center providing consultation to families. The company holds FACT, AABB, ESYD ISO 15189, ISO 9001, and GMP certifications alongside a Greek Ministry of Health operating license, and operates 8 offices across Greece plus international offices in Cyprus, Italy (through wholly-owned subsidiary Bioitaly SRL), Serbia, Bulgaria, North Macedonia, and the Philippines.

The company is led by academic founders — Dr. Georgios Koliakos (Emeritus Professor of Biochemistry, Aristotle University of Thessaloniki) and Dr. Kokkona Kouzi-Koliakou (Emeritus Professor of Histology-Embryology, AUTH) — with deep translational research credentials (202 and 62 publications respectively, h-index 40) and 5 patents in cellular therapy. The company claims to have performed the first therapeutic use of stem cells in Greece in 2009 and reports 50,000+ families served.

Biohellenika generates revenue through a mix of subscription recurring storage fees (annual cadence for long-term cryopreservation) and one-time service fees for NIPT, paternity testing, genetic profiling, and PRP treatments, with a primary customer segment of expectant parents seeking biological insurance for potential future therapeutic use. Distribution is sales-led via direct offices, parent seminars, medical referrals (obstetricians/gynecologists), and the company website, supported by healthcare professional networks across both Greek and international markets. R&D is partially funded through ESPA (EU/Greece) research programs including Proderma and ArthroMicroPerMed for skin regeneration patch development.

Short descriptiontext

Greek stem cell bank founded in 2006 specializing in cord blood, cord tissue, and placenta cryopreservation, complemented by molecular diagnostics (NIPT, paternity, pharmacogenomics) and PRP therapies, serving 50,000+ families across Greece and six international markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAthens, Greece
HQ citystring
Athens
HQ countrystring
Greece
HQ regionstring
Europe
Markets served

Serves global market

Offices14 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
stem cell banking, cord blood storage, prenatal genetic testing, cryopreservation services, molecular diagnostics
Industry3 codes
PRIMARYHLAAAGAE
Cell & Tissue Banking (biobanking, cord blood/tissue)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAFAMAH
Genetic & Prenatal Testing Laboratories
SECONDARYHLAHAAAI
Genetic, Cytogenetic & Prenatal Screening IVD
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
NAICS code2 codes
  • Blood and Organ Banks621991
  • Medical Laboratories621511
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Stem Cell Banking Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Stem Cell Banking Services
TypeSubscription Recurring
Description

Collection, processing, and long-term cryopreservation of stem cells from cord blood, cord tissue, and placenta at birth. Services include initial processing and annual storage fees.

biohellenika.gr
2Prenatal Testing (NIPT)
TypeOne Time License
Description

Non-invasive prenatal testing from maternal blood for detection of chromosomal abnormalities including Down syndrome.

biohellenika.gr
3Molecular Laboratory Services
TypeOne Time License
Description

DNA testing including paternity tests, prenatal paternity, HPV detection, celiac/lactose intolerance testing, genetic profiling, pharmacogenomics, cardiovascular disease testing, microbiome analysis, and infertility diagnostics.

biohellenika.gr
4PRP Treatments
TypeProfessional Services
Description

Platelet-rich plasma treatments for orthopedics, gynecology, and aesthetic medicine including individualized facial creams.

biohellenika.gr
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Pricing details1 tier
1Stem Cell Storage Annual Subscription
ModelSubscriptionBilling cadenceAnnual
Notes

Annual storage fees for stem cell preservation. Contract renewal is required to maintain storage beyond initial term. Pro-rata refund available if storage period has not commenced.

biohellenika.gr
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Biohellenika collects, processes, and cryopreserves hematopoietic and mesenchymal stem cells from umbilical cord blood, cord tissue, and placenta at childbirth, offering long-term storage under FACT and AABB international accreditations. The company also operates a molecular diagnostic laboratory providing NIPT prenatal screening, paternity testing, genetic profiling, pharmacogenomics, HPV detection, karyotyping, and PRP treatments in orthopedics, gynecology, and aesthetics.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 50,000+ families have trusted Biohellenika for stem cell banking services
+3 more records
Product overview1 text field

Biohellenika is a licensed stem cell bank offering a comprehensive portfolio of biological storage and genetic testing services. The core offering is stem cell banking from umbilical cord blood and tissue collected at childbirth, with associated molecular laboratory services including prenatal testing (NIPT), DNA paternity testing, and various genetic analysis tests. Additional services include PRP (platelet-rich plasma) applications for orthopedics, gynecology, and aesthetic medicine, plus a medical consulting center. The company also conducts research through EU-funded programs (Proderma, ArthroMicroPerMed). The product ecosystem centers on cord blood banking with multiple collection methods, supported by an accredited molecular diagnostic laboratory offering genetic testing services, and enhanced by PRP therapeutic applications.

Product and service18 records
1Cord Blood Stem Cell Banking
CategoryStem Cell Banking
2Umbilical Cord Tissue (Mesenchymal) Stem Cell Storage
CategoryStem Cell Banking
3VSELs Collection (Very Small Embryonic-Like Stem Cells)
CategoryStem Cell Banking
4Second Collection of Umbilical Cord Blood from Placenta
CategoryStem Cell Banking
5Non-Invasive Prenatal Test (NIPT)
CategoryGenetic Testing Services
6DNA Paternity Testing
CategoryGenetic Testing Services
7Genetic Profile Analysis
CategoryGenetic Testing Services
Description

Genetic profiling test for inherited conditions and predispositions, supporting family health planning and personalized medicine decisions.

8Pharmacogenomics Testing
CategoryGenetic Testing Services
9Cardiovascular Diseases & Thrombosis Testing
CategoryGenetic Testing Services
10Prenatal Karyotype Analysis
CategoryGenetic Testing Services
11Infertility Testing
CategoryGenetic Testing Services
12HPV Detection
CategoryGenetic Testing Services
13Celiac Disease & Lactose Intolerance Testing
CategoryGenetic Testing Services
14Nutritional Test
CategoryGenetic Testing Services
15PRP in Orthopedics
CategoryPRP Treatments
16PRP in Gynecology
CategoryPRP Treatments
17Individualized PRP Facial Cream
CategoryPRP Treatments / Aesthetic Products
18Medical Advisory Center Consulting
CategoryMedical Consulting Services
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
1NANOTYPOS O.E.
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Nanoprinting research and development company collaborating on the ArthroMicroPerMed program for development of innovative polymeric patches with antimicrobial activity supplemented with extracellular matrix components and stem cells for skin regeneration.

biohellenika.gr
2Professor Bikiaris Research Team
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborating on the ArthroMicroPerMed project for development of advanced polymeric materials for skin regeneration combined with stem cells. The team has necessary experience and appropriate laboratory equipment for development of new advanced polymeric materials.

biohellenika.gr
3Bioitaly SRL
Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

International subsidiary operation in Italy located in Catania, providing stem cell banking services to the Italian market.

biohellenika.gr
Strategic tierCoreTypeOthers
Description

Co-funded by Greece and the European Union through ESPA programs for research and development projects including the ArthroMicroPerMed project and Proderma program for innovative skin regeneration patches.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

US-based family cord blood bank owned by Revvity (formerly PerkinElmer); broad incumbent with global brand recognition and full accreditation stack comparable to Biohellenika.

TypeDirect peer
Description

German private cord blood bank publicly listed; closest EU direct peer with similar subscription model, comparable accreditations, and multi-country presence across Central and SE Europe.

TypeRegional player
Description

Singapore-based family cord blood bank with Asia-Pacific focus; comparable service offering with Biohellenika's Philippines presence and provides insight into how Biohellenika could expand in SE Asia.

TypeBroad incumbent
Description

European-wide diagnostic laboratory network offering paternity, NIPT, and genetic testing; broad incumbent that could compete with Biohellenika's molecular laboratory services across SE European markets.

TypeBroad incumbent
Description

Largest US private cord blood bank, now part of CooperCompanies; provides global scale benchmarking for what Biohellenika could achieve with continued international expansion.

TypeDirect peer
Description

Largest cord blood bank in Europe, operating PBKM (Poland) and FamiCord (Germany) brands with multiple country presence; directly comparable to Biohellenika as a private/family cord blood bank with international expansion and similar AABB/FACT accreditation focus.

TypeBroad incumbent
Description

Large US-based genetic testing company with Panorama NIPT and broader reproductive health testing portfolio; competes directly with Biohellenika's NIPT/Nativa Test and molecular laboratory service line.

TypeDirect peer
Description

UK-headquartered cord blood bank serving international markets; directly comparable service offering with emphasis on VSELs and mesenchymal stem cell storage, similar technology portfolio to Biohellenika.

TypeDirect peer
Description

European-headquartered family cord blood bank with operations in multiple countries; direct competitor offering cord blood and cord tissue storage with comparable recurring subscription model and EU consumer-protection compliance.

TypeDirect peer
Description

UK-based private cord blood and cord tissue bank with international distribution; competes in the same expectant-parent segment with similar subscription-based service model and cell-processing technology.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biohellenika

Stem Cell Banking Servicesbiohellenika.gr

Greek stem cell bank founded in 2006 specializing in cord blood, cord tissue, and placenta cryopreservation, complemented by molecular diagnostics (NIPT, paternity, pharmacogenomics) and PRP therapies, serving 50,000+ families across Greece and six international markets.

What Biohellenika does

Biohellenika is a Greek biotechnology company founded in 2006 in Thessaloniki, specializing in the collection, processing, and long-term cryogenic storage of hematopoietic and mesenchymal stem cells from umbilical cord blood, umbilical cord tissue, and placenta at childbirth. The company also collects Very Small Embryonic-Like Stem Cells (VSELs) from cord blood and operates an in-house molecular laboratory offering non-invasive prenatal testing (NIPT), DNA paternity testing, pharmacogenomics, cardiovascular and thrombosis testing, HPV detection, celiac/lactose intolerance testing, microbiome analysis, and infertility diagnostics. Additional service lines include platelet-rich plasma (PRP) applications in orthopedics, gynecology, and individualized facial skincare, plus a Medical Advisory Center providing consultation to families. The company holds FACT, AABB, ESYD ISO 15189, ISO 9001, and GMP certifications alongside a Greek Ministry of Health operating license, and operates 8 offices across Greece plus international offices in Cyprus, Italy (through wholly-owned subsidiary Bioitaly SRL), Serbia, Bulgaria, North Macedonia, and the Philippines.

The company is led by academic founders — Dr. Georgios Koliakos (Emeritus Professor of Biochemistry, Aristotle University of Thessaloniki) and Dr. Kokkona Kouzi-Koliakou (Emeritus Professor of Histology-Embryology, AUTH) — with deep translational research credentials (202 and 62 publications respectively, h-index 40) and 5 patents in cellular therapy. The company claims to have performed the first therapeutic use of stem cells in Greece in 2009 and reports 50,000+ families served.

Biohellenika generates revenue through a mix of subscription recurring storage fees (annual cadence for long-term cryopreservation) and one-time service fees for NIPT, paternity testing, genetic profiling, and PRP treatments, with a primary customer segment of expectant parents seeking biological insurance for potential future therapeutic use. Distribution is sales-led via direct offices, parent seminars, medical referrals (obstetricians/gynecologists), and the company website, supported by healthcare professional networks across both Greek and international markets. R&D is partially funded through ESPA (EU/Greece) research programs including Proderma and ArthroMicroPerMed for skin regeneration patch development.

Biohellenika firmographics

Firmographics
Name
Biohellenika
Legal name
BIOHELLENIKA ΑΝΩΝΥΜΟΣ ΕΤΑΙΡΙΑ – ΕΤΑΙΡΙΑ ΕΝΤΑΣΗΣ ΓΝΩΣΗΣ – ΜΕΤΑΦΟΡΑΣ ΤΕΧΝΟΓΝΩΣΙΑΣ – ΤΕΧΝΟΛΟΓΙΑΣ – ΒΙΟΤΕΧΝΟΛΟΓΙΑΣ – ΠΑΡΟΧΗΣ ΥΠΗΡΕΣΙΩΝ ΚΑΙ ΣΥΜΒΟΥΛΩΝ
Website
https://biohellenika.gr
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
11–50 employees
Short description
Greek stem cell bank founded in 2006 specializing in cord blood, cord tissue, and placenta cryopreservation, complemented by molecular diagnostics (NIPT, paternity, pharmacogenomics) and PRP therapies, serving 50,000+ families across Greece and six international markets.
Ownership category
akta.pro rank

Biohellenika industry classification

Industry
Product category
Stem Cell Banking Services
NAICS
Blood and Organ Banks (621991), Medical Laboratories (621511)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAAAGAE
Cell & Tissue Banking (biobanking, cord blood/tissue)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAFAMAH
Genetic & Prenatal Testing Laboratories
SECONDARYHLAHAAAI
Genetic, Cytogenetic & Prenatal Screening IVD
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

Keywords

  • Stem cell banking
  • Cord blood storage
  • Prenatal genetic testing
  • Cryopreservation services
  • Molecular diagnostics

Where Biohellenika is headquartered

Location

Headquarters

HQ city
Athens
HQ country
Greece
HQ region
Europe

Offices14 records

Markets served

Biohellenika business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

  1. Stem Cell Banking Services: Collection, processing, and long-term cryopreservation of stem cells from cord blood, cord tissue, and placenta at birth. Services include initial processing and annual storage fees.
  2. Prenatal Testing (NIPT): Non-invasive prenatal testing from maternal blood for detection of chromosomal abnormalities including Down syndrome.
  3. Molecular Laboratory Services: DNA testing including paternity tests, prenatal paternity, HPV detection, celiac/lactose intolerance testing, genetic profiling, pharmacogenomics, cardiovascular disease testing, microbiome analysis, and infertility diagnostics.
  4. PRP Treatments: Platelet-rich plasma treatments for orthopedics, gynecology, and aesthetic medicine including individualized facial creams.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualStem Cell Storage Annual Subscription

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Biohellenika product offering

Product offering

Core offering

Biohellenika collects, processes, and cryopreserves hematopoietic and mesenchymal stem cells from umbilical cord blood, cord tissue, and placenta at childbirth, offering long-term storage under FACT and AABB international accreditations. The company also operates a molecular diagnostic laboratory providing NIPT prenatal screening, paternity testing, genetic profiling, pharmacogenomics, HPV detection, karyotyping, and PRP treatments in orthopedics, gynecology, and aesthetics.

Product overview

Biohellenika is a licensed stem cell bank offering a comprehensive portfolio of biological storage and genetic testing services. The core offering is stem cell banking from umbilical cord blood and tissue collected at childbirth, with associated molecular laboratory services including prenatal testing (NIPT), DNA paternity testing, and various genetic analysis tests. Additional services include PRP (platelet-rich plasma) applications for orthopedics, gynecology, and aesthetic medicine, plus a medical consulting center. The company also conducts research through EU-funded programs (Proderma, ArthroMicroPerMed). The product ecosystem centers on cord blood banking with multiple collection methods, supported by an accredited molecular diagnostic laboratory offering genetic testing services, and enhanced by PRP therapeutic applications.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cord Blood Stem Cell Banking
  • Umbilical Cord Tissue (Mesenchymal) Stem Cell Storage
  • VSELs Collection (Very Small Embryonic-Like Stem Cells)
  • Second Collection of Umbilical Cord Blood from Placenta
  • Non-Invasive Prenatal Test (NIPT)
  • DNA Paternity Testing
  • Genetic Profile Analysis Genetic profiling test for inherited conditions and predispositions, supporting family health planning and personalized medicine decisions.
  • Pharmacogenomics Testing
  • Cardiovascular Diseases & Thrombosis Testing
  • Prenatal Karyotype Analysis
  • Infertility Testing
  • HPV Detection
  • Celiac Disease & Lactose Intolerance Testing
  • Nutritional Test
  • PRP in Orthopedics
  • PRP in Gynecology
  • Individualized PRP Facial Cream
  • Medical Advisory Center Consulting

Quantifiable outcome

  • 50,000+ families have trusted Biohellenika for stem cell banking services
  • +3 more outcomes

Companies that use Biohellenika

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Biohellenika technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Biohellenika partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and regional.

  • NANOTYPOS O.E.coreStrategic or Co-development PartnerNanoprinting research and development company collaborating on the ArthroMicroPerMed program for development of innovative polymeric patches with antimicrobial activity supplemented with extracellular matrix components and stem cells for skin regeneration.
  • Professor Bikiaris Research TeamcoreStrategic or Co-development PartnerCollaborating on the ArthroMicroPerMed project for development of advanced polymeric materials for skin regeneration combined with stem cells. The team has necessary experience and appropriate laboratory equipment for development of new advanced polymeric materials.
  • Bioitaly SRLregionalChannel Partner/ Reseller/ DistributorInternational subsidiary operation in Italy located in Catania, providing stem cell banking services to the Italian market.
  • ESPA (National Strategic Reference Framework)coreOthersCo-funded by Greece and the European Union through ESPA programs for research and development projects including the ArthroMicroPerMed project and Proderma program for innovative skin regeneration patches.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Biohellenika competitors and assessment

Company assessment

Broad incumbents

  • ViaCord: US-based family cord blood bank owned by Revvity (formerly PerkinElmer); broad incumbent with global brand recognition and full accreditation stack comparable to Biohellenika.
  • Eurofins Genomics: European-wide diagnostic laboratory network offering paternity, NIPT, and genetic testing; broad incumbent that could compete with Biohellenika's molecular laboratory services across SE European markets.
  • Cord Blood Registry (CBR): Largest US private cord blood bank, now part of CooperCompanies; provides global scale benchmarking for what Biohellenika could achieve with continued international expansion.
  • Natera: Large US-based genetic testing company with Panorama NIPT and broader reproductive health testing portfolio; competes directly with Biohellenika's NIPT/Nativa Test and molecular laboratory service line.

Direct peers

  • Vita 34: German private cord blood bank publicly listed; closest EU direct peer with similar subscription model, comparable accreditations, and multi-country presence across Central and SE Europe.
  • FamiCord Group: Largest cord blood bank in Europe, operating PBKM (Poland) and FamiCord (Germany) brands with multiple country presence; directly comparable to Biohellenika as a private/family cord blood bank with international expansion and similar AABB/FACT accreditation focus.
  • Smart Cells International: UK-headquartered cord blood bank serving international markets; directly comparable service offering with emphasis on VSELs and mesenchymal stem cell storage, similar technology portfolio to Biohellenika.
  • Cryo-Save (Esperite): European-headquartered family cord blood bank with operations in multiple countries; direct competitor offering cord blood and cord tissue storage with comparable recurring subscription model and EU consumer-protection compliance.
  • Cells4Life: UK-based private cord blood and cord tissue bank with international distribution; competes in the same expectant-parent segment with similar subscription-based service model and cell-processing technology.

Regional players

  • StemCord: Singapore-based family cord blood bank with Asia-Pacific focus; comparable service offering with Biohellenika's Philippines presence and provides insight into how Biohellenika could expand in SE Asia.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Biohellenika social profiles

Digital presence

Biohellenika compliance and trust

Trust signal

Compliance8 records

Biohellenika financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biohellenika leadership team

Management profile

Number of profiles

Profiles6 records

Biohellenika subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Biohellenika funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biohellenika M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biohellenika

What does Biohellenika do?

Biohellenika collects, processes, and cryopreserves hematopoietic and mesenchymal stem cells from umbilical cord blood, cord tissue, and placenta at childbirth, offering long-term storage under FACT and AABB international accreditations. The company also operates a molecular diagnostic laboratory providing NIPT prenatal screening, paternity testing, genetic profiling, pharmacogenomics, HPV detection, karyotyping, and PRP treatments in orthopedics, gynecology, and aesthetics.

Is Biohellenika a public or private company?

Biohellenika is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Biohellenika founded?

Biohellenika was founded in 2006. It employs 11 to 50 people.

Where is Biohellenika based?

Biohellenika is headquartered in Athens, Greece, in the Europe region.

How does Biohellenika make money?

Four revenue lines are on record. Stem Cell Banking Services are the primary driver. The others are prenatal Testing (NIPT), molecular Laboratory Services and PRP Treatments.

Who are Biohellenika's main competitors?

Broad incumbents on record are ViaCord, Eurofins Genomics, Cord Blood Registry (CBR) and Natera. Direct peers are Vita 34, FamiCord Group, Smart Cells International, Cryo-Save (Esperite) and Cells4Life. StemCord is listed as a regional player.

Does Biohellenika have an API?

No public API is recorded for Biohellenika.

What industry is Biohellenika in?

Biohellenika's product category is Stem Cell Banking Services. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue), with a secondary code of HLAFAMAH, Genetic & Prenatal Testing Laboratories. Its NAICS code is 621991 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales